BOSTON, Jan. 08, 2026 -- Aktis Oncology, Inc. (“Aktis”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed...
Mike Grey will join a panel to discuss the future of venture capital in life sciences investing at a special event hosted by the San Diego Venture Group on September 27 in San Diego, CA.
News | 09. 20. 2012
Mike Grey will join a panel to discuss the future of venture capital in life sciences investing at a special event hosted by the San Diego Venture Group on September 27 in San Diego, CA.
